Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

(2022) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis

(2022) Lihui Wang et al.   Bioengineered

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p

(2021) Junmin Li et al.   Cancer Cell International

Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway

(2021) Jianhao Xu et al.   Aging-US

Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis

(2021) Dongjie Du et al.   CYTOTECHNOLOGY

Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis

(2021) Yumei Bai et al.   Journal of Orthopaedic Surgery and Research

Circ_PTN contributes to the cisplatin-resistance of glioblastoma cells via stimulating PI3K/AKT signaling through miR-542-3p/PIK3R3 pathway

(2021) Hongcheng Luo et al.   Molecular Therapy-Nucleic Acids

Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation

(2021) Ganghua Yang et al.   CELLULAR SIGNALLING

Circ_0134944 inhibits osteogenesis through miR-127-5p/PDX1/SPHK1 pathway

(2021) Da-Wei Zhang et al.   Regenerative Therapy

Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis

(2020) Weiping Yang et al.   Cancer Management and Research

Circ_0007331 knock‐down suppresses the progression of endometriosis via miR‐200c‐3p/HiF‐1α axis

(2020) Lan Dong et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)

(2020) Weijun Hong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p

(2018) Tongmiao Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hsa_circ_0033155: A potential novel biomarker for non‑small cell lung cancer

(2018) Xiaohua Gu et al.   Experimental and Therapeutic Medicine

Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non–Small-Cell Lung Cancer in South Carolina

(2017) Jarrod T. Bullard et al.   SOUTHERN MEDICAL JOURNAL

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) S. Novello et al.   ANNALS OF ONCOLOGY

Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells

(2015) Honglin Dong et al.   Journal of Cancer Research and Therapeutics

Circular RNAs are abundant, conserved, and associated with ALU repeats

(2012) W. R. Jeck et al.   RNA